J Bone Miner Res. 2015 May;30(5):929-33. doi: 10.1002/jbmr.2410.

We conclude that the effects of bisphosphonates on fracture prevention in osteogenesis imperfecta are inconclusive. Adequately powered trials with a fracture endpoint are needed to further investigate the risks and benefits of bisphosphonates in this condition.

Autor: Hald JD, Evangelou E, Langdahl BL, Ralston SH.

Leave a Reply

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

  • 19 + 14 =